Platelet chemokines in vascular disease.

PubWeight™: 1.51‹?› | Rank: Top 4%

🔗 View Article (PMC 2657037)

Published in Arterioscler Thromb Vasc Biol on August 21, 2008

Authors

Christian A Gleissner1, Philipp von Hundelshausen, Klaus Ley

Author Affiliations

1: Division of Inflammation Biology, La Jolla Institute for Allergy and Immunology, La Jolla, California 92037, USA.

Articles citing this

Platelet alpha-granules: basic biology and clinical correlates. Blood Rev (2009) 2.72

Duffy antigen receptor for chemokines (Darc) polymorphism regulates circulating concentrations of monocyte chemoattractant protein-1 and other inflammatory mediators. Blood (2009) 2.27

Platelet CD40L mediates thrombotic and inflammatory processes in atherosclerosis. Blood (2010) 1.86

How leukocytes cross the vascular endothelium. Nat Rev Immunol (2015) 1.44

CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J Immunol (2010) 1.41

Runx2-upregulated receptor activator of nuclear factor κB ligand in calcifying smooth muscle cells promotes migration and osteoclastic differentiation of macrophages. Arterioscler Thromb Vasc Biol (2011) 1.34

Chemokine receptor CCR5: from AIDS to atherosclerosis. Br J Pharmacol (2011) 1.29

Phenotypic polarization of macrophages in atherosclerosis. Arterioscler Thromb Vasc Biol (2013) 1.29

Red blood cell microparticles show altered inflammatory chemokine binding and release ligand upon interaction with platelets. Transfusion (2010) 1.28

Platelets guide the formation of early metastatic niches. Proc Natl Acad Sci U S A (2014) 1.24

CXCL4 downregulates the atheroprotective hemoglobin receptor CD163 in human macrophages. Circ Res (2009) 1.13

Role of platelets in neuroinflammation: a wide-angle perspective. J Neuroinflammation (2010) 1.11

Platelets: a critical link between inflammation and microvascular dysfunction. J Physiol (2011) 1.10

Platelets and cancer: a casual or causal relationship: revisited. Cancer Metastasis Rev (2014) 1.07

Integrated clinical, pathologic, virologic, and transcriptomic analysis of H5N1 influenza virus-induced viral pneumonia in the rhesus macaque. J Virol (2012) 1.05

Macrophage Phenotype Modulation by CXCL4 in Atherosclerosis. Front Physiol (2012) 1.05

Platelet secretion: From haemostasis to wound healing and beyond. Blood Rev (2014) 1.03

Plasmodium coatneyi in rhesus macaques replicates the multisystemic dysfunction of severe malaria in humans. Infect Immun (2013) 1.03

Carcinoma mucins trigger reciprocal activation of platelets and neutrophils in a murine model of Trousseau syndrome. Blood (2011) 1.00

Storage of murine red blood cells enhances alloantibody responses to an erythroid-specific model antigen. Transfusion (2009) 1.00

Plasma cytokine concentrations indicate that in vivo hormonal regulation of immunity is altered during long-duration spaceflight. J Interferon Cytokine Res (2014) 0.98

Platelet-derived SDF-1 primes the pulmonary capillary vascular niche to drive lung alveolar regeneration. Nat Cell Biol (2015) 0.95

Clopidogrel, a platelet P2Y12 receptor inhibitor, reduces vascular inflammation and angiotensin II induced-abdominal aortic aneurysm progression. PLoS One (2012) 0.91

Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. Mediators Inflamm (2010) 0.90

Correlation between albuminuria and spontaneous platelet microaggregate formation in type 2 diabetic patients. Diabetes Care (2009) 0.90

Genetic variants in Arhgef11 are associated with kidney injury in the Dahl salt-sensitive rat. Hypertension (2012) 0.89

Monocytes/macrophages express chemokine receptor CCR9 in rheumatoid arthritis and CCL25 stimulates their differentiation. Arthritis Res Ther (2010) 0.88

Platelets and atherogenesis: Platelet anti-aggregation activity and endothelial protection from tomatoes (Solanum lycopersicum L.). Exp Ther Med (2012) 0.87

Transcriptomic analysis of the stress response to weaning at housing in bovine leukocytes using RNA-seq technology. BMC Genomics (2012) 0.86

Contribution of blood platelets to vascular pathology in Alzheimer's disease. J Blood Med (2013) 0.85

SDF-1α is a novel autocrine activator of platelets operating through its receptor CXCR4. Cell Signal (2014) 0.85

Genome-wide association studies in atherosclerosis. Curr Atheroscler Rep (2011) 0.84

Coronary artery remodeling in a model of left ventricular pressure overload is influenced by platelets and inflammatory cells. PLoS One (2012) 0.83

Platelet-neutrophil interactions under thromboinflammatory conditions. Cell Mol Life Sci (2015) 0.82

Cytokine network in scrub typhus: high levels of interleukin-8 are associated with disease severity and mortality. PLoS Negl Trop Dis (2014) 0.82

Plasmodium falciparum infection induces expression of a mosquito salivary protein (Agaphelin) that targets neutrophil function and inhibits thrombosis without impairing hemostasis. PLoS Pathog (2014) 0.81

Changes in transcriptome of macrophages in atherosclerosis. J Cell Mol Med (2015) 0.80

Platelet secretion of CXCL4 is Rac1-dependent and regulates neutrophil infiltration and tissue damage in septic lung damage. Br J Pharmacol (2015) 0.79

Alternative C-terminal helix orientation alters chemokine function: structure of the anti-angiogenic chemokine, CXCL4L1. J Biol Chem (2013) 0.79

Platelet Supernatant Suppresses LPS-Induced Nitric Oxide Production from Macrophages Accompanied by Inhibition of NF-κB Signaling and Increased Arginase-1 Expression. PLoS One (2016) 0.78

Platelet-derived CXCL12 regulates monocyte function, survival, differentiation into macrophages and foam cells through differential involvement of CXCR4-CXCR7. Cell Death Dis (2015) 0.78

Neutrophils in atherosclerosis: alarmin evidence of a hit and run? Circ Res (2012) 0.78

Markers of Blood Cell Activation and Complement Activation in Factor VIII and von Willebrand Factor Concentrates. Transfus Med Hemother (2010) 0.77

An In Vitro Investigation of Platelet-Rich Plasma-Gel as a Cell and Growth Factor Delivery Vehicle for Tissue Engineering. Tissue Eng Part C Methods (2015) 0.77

Gingipains: Critical Factors in the Development of Aspiration Pneumonia Caused by Porphyromonas gingivalis. J Innate Immun (2015) 0.77

Molecular Imaging of Platelet-Endothelial Interactions and Endothelial von Willebrand Factor in Early and Mid-Stage Atherosclerosis. Circ Cardiovasc Imaging (2015) 0.77

Time course of cardiac inflammation during nitric oxide synthase inhibition in SHR: impact of prior transient ACE inhibition. Hypertens Res (2015) 0.77

CXCL4 and CXCL4L1 Differentially Affect Monocyte Survival and Dendritic Cell Differentiation and Phagocytosis. PLoS One (2016) 0.77

Microdialysis Sampling from Wound Fluids Enables Quantitative Assessment of Cytokines, Proteins, and Metabolites Reveals Bone Defect-Specific Molecular Profiles. PLoS One (2016) 0.76

Hyperglycemia enhances arsenic-induced platelet and megakaryocyte activation. J Transl Med (2017) 0.75

Involvement of Visceral Adipose Tissue in Immunological Modulation of Inflammatory Cascade in Preeclampsia. Mediators Inflamm (2015) 0.75

PPBP and DEFA1/DEFA3 genes in hyperlipidaemia as feasible synergistic inflammatory biomarkers for coronary heart disease. Lipids Health Dis (2017) 0.75

Platelets and von Willebrand factor in atherogenesis. Blood (2017) 0.75

Platelet-Derived Chemokine CXCL7 Dimer Preferentially Exists in the Glycosaminoglycan-Bound Form: Implications for Neutrophil-Platelet Crosstalk. Front Immunol (2017) 0.75

Articles cited by this

Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med (2005) 28.21

The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature (1993) 27.07

Chemokines: a new classification system and their role in immunity. Immunity (2000) 13.03

The biology of chemokines and their receptors. Annu Rev Immunol (2000) 9.81

Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature (1998) 8.92

Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A (1997) 5.54

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature (1998) 5.21

Dynamic visualization of thrombopoiesis within bone marrow. Science (2007) 4.35

MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature (1999) 4.19

Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med (2002) 4.02

RANTES deposition by platelets triggers monocyte arrest on inflamed and atherosclerotic endothelium. Circulation (2001) 3.86

Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 3.83

Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature (1998) 3.31

MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest (1999) 3.21

Cytokine RANTES released by thrombin-stimulated platelets is a potent attractant for human eosinophils. J Exp Med (1992) 3.20

Platelet factor 4 is chemotactic for neutrophils and monocytes. Proc Natl Acad Sci U S A (1981) 3.03

An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J Exp Med (2003) 2.91

Platelet alpha-granule proteins: studies on release and subcellular localization. Blood (1979) 2.74

Absence of CC chemokine receptor-2 reduces atherosclerosis in apolipoprotein E-deficient mice. Atherosclerosis (1999) 2.35

Platelets as immune cells: bridging inflammation and cardiovascular disease. Circ Res (2007) 2.22

Response to injury and atherogenesis. Am J Pathol (1977) 2.09

Elimination of platelet factor 4 (PF4) from platelets reduces atherosclerosis in C57Bl/6 and apoE-/- mice. Thromb Haemost (2007) 2.00

Effects of the neutrophil-activating peptide NAP-2, platelet basic protein, connective tissue-activating peptide III and platelet factor 4 on human neutrophils. J Exp Med (1989) 1.98

Activated platelets induce monocyte chemotactic protein-1 secretion and surface expression of intercellular adhesion molecule-1 on endothelial cells. Circulation (1998) 1.95

Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation (2003) 1.94

Platelet factor 4 localization in carotid atherosclerotic plaques: correlation with clinical parameters. Thromb Haemost (2003) 1.91

Requirement for CD154 in the progression of atherosclerosis. Nat Med (1999) 1.86

Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression. Am J Pathol (2006) 1.67

Role of platelets in the development of atherosclerosis. Trends Cardiovasc Med (2004) 1.61

Heterophilic interactions of platelet factor 4 and RANTES promote monocyte arrest on endothelium. Blood (2004) 1.61

The stromal cell-derived factor-1 chemokine is a potent platelet agonist highly expressed in atherosclerotic plaques. Circ Res (2000) 1.60

Thrombocidins, microbicidal proteins from human blood platelets, are C-terminal deletion products of CXC chemokines. J Biol Chem (2000) 1.58

The CXC-chemokine platelet factor 4 promotes monocyte survival and induces monocyte differentiation into macrophages. Blood (2000) 1.52

Neutrophil-activating peptides NAP-2 and IL-8 bind to the same sites on neutrophils but interact in different ways. Discrepancies in binding affinities, receptor densities, and biologic effects. J Immunol (1994) 1.52

Induction of dendritic cell-like phenotype in macrophages during foam cell formation. Physiol Genomics (2007) 1.51

Platelets and chemokines in atherosclerosis: partners in crime. Circ Res (2005) 1.51

Importance of CXC chemokine receptor 2 in the homing of human peripheral blood endothelial progenitor cells to sites of arterial injury. Circ Res (2007) 1.49

Megakaryocytes and beyond: the birth of platelets. J Thromb Haemost (2003) 1.47

Release of platelet factor 4 in vivo during intravascular coagulation and in thrombotic states. Thromb Diath Haemorrh (1968) 1.41

Platelet-derived stromal cell-derived factor-1 regulates adhesion and promotes differentiation of human CD34+ cells to endothelial progenitor cells. Circulation (2007) 1.39

CXCR3-mediated opposite effects of CXCL10 and CXCL4 on TH1 or TH2 cytokine production. J Allergy Clin Immunol (2005) 1.35

Platelet factor 4 is a negative autocrine in vivo regulator of megakaryopoiesis: clinical and therapeutic implications. Blood (2007) 1.34

The beta-thromboglobulins and platelet factor 4: blood platelet-derived CXC chemokines with divergent roles in early neutrophil regulation. J Leukoc Biol (2000) 1.31

Platelet-derived chemokines in vascular biology. Thromb Haemost (2007) 1.27

Regulation of endothelial progenitor cell homing after arterial injury. Thromb Haemost (2007) 1.27

Functional expression of CCR1, CCR3, CCR4, and CXCR4 chemokine receptors on human platelets. Blood (2000) 1.24

Platelet-derived CXC chemokines: old players in new games. Immunol Rev (2000) 1.21

Regulation of adhesion of CD4+ T lymphocytes to intact or heparinase-treated subendothelial extracellular matrix by diffusible or anchored RANTES and MIP-1 beta. J Immunol (1994) 1.21

GRO family chemokines are specialized for monocyte arrest from flow. Am J Physiol Heart Circ Physiol (2005) 1.20

Platelet chemokines and their receptors: what is their relevance to platelet storage and transfusion practice? Transfus Med (2001) 1.19

Platelets release CXCL4L1, a nonallelic variant of the chemokine platelet factor-4/CXCL4 and potent inhibitor of angiogenesis. Circ Res (2004) 1.18

The CXC-chemokine neutrophil-activating peptide-2 induces two distinct optima of neutrophil chemotaxis by differential interaction with interleukin-8 receptors CXCR-1 and CXCR-2. Blood (1997) 1.17

CC chemokine ligand-5 (CCL5/RANTES) and CC chemokine ligand-18 (CCL18/PARC) are specific markers of refractory unstable angina pectoris and are transiently raised during severe ischemic symptoms. Circulation (2007) 1.17

CXCL4-induced migration of activated T lymphocytes is mediated by the chemokine receptor CXCR3. J Leukoc Biol (2008) 1.16

Endothelial expression of E-selectin is induced by the platelet-specific chemokine platelet factor 4 through LRP in an NF-kappaB-dependent manner. Blood (2004) 1.11

Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Blood (1999) 1.09

Expression of HIF-1alpha in injured arteries controls SDF-1alpha mediated neointima formation in apolipoprotein E deficient mice. Arterioscler Thromb Vasc Biol (2007) 1.09

Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler Thromb Vasc Biol (1998) 1.09

Structural and functional comparison of the genes for human platelet factor 4 and PF4alt. Blood (1990) 1.07

Circulating chemokines accurately identify individuals with clinically significant atherosclerotic heart disease. Physiol Genomics (2007) 1.05

Platelet factor 4/CXCL4-stimulated human monocytes induce apoptosis in endothelial cells by the release of oxygen radicals. J Leukoc Biol (2008) 1.05

Platelet-derived chemokines CXC chemokine ligand (CXCL)7, connective tissue-activating peptide III, and CXCL4 differentially affect and cross-regulate neutrophil adhesion and transendothelial migration. J Immunol (2002) 1.04

Activated platelets trigger an inflammatory response and enhance migration of aortic smooth muscle cells. Thromb Res (2003) 1.03

Platelet factor 4 enhances the binding of oxidized low-density lipoprotein to vascular wall cells. J Biol Chem (2002) 1.02

Platelet factor 4 inhibits proliferation and cytokine release of activated human T cells. J Immunol (2002) 1.02

Characterization of a neutrophil cell surface glycosaminoglycan that mediates binding of platelet factor 4. J Biol Chem (1999) 1.01

Novel role of the membrane-bound chemokine fractalkine in platelet activation and adhesion. Blood (2003) 1.01

TNF-alpha renders human neutrophils responsive to platelet factor 4. Comparison of PF-4 and IL-8 reveals different activity profiles of the two chemokines. J Immunol (1996) 0.99

The CC chemokines MDC and TARC induce platelet activation via CCR4. Thromb Res (2001) 0.98

Adenosine diphosphate strongly potentiates the ability of the chemokines MDC, TARC, and SDF-1 to stimulate platelet function. Blood (2001) 0.98

Platelet factor 4 binds to low-density lipoprotein receptors and disrupts the endocytic machinery, resulting in retention of low-density lipoprotein on the cell surface. Blood (2002) 0.97

Platelet factor 4/CXCL4 induces phagocytosis and the generation of reactive oxygen metabolites in mononuclear phagocytes independently of Gi protein activation or intracellular calcium transients. J Immunol (2004) 0.97

Differential and additive effects of platelet-derived chemokines on monocyte arrest on inflamed endothelium under flow conditions. J Leukoc Biol (2005) 0.95

Platelet microbicidal activity is an important defense factor against viridans streptococcal endocarditis. J Infect Dis (2001) 0.94

Effect of CXC chemokine platelet factor 4 on differentiation and function of monocyte-derived dendritic cells. Int Immunol (2003) 0.93

Platelet factor 4 in conjunction with IL-4 directs differentiation of human monocytes into specialized antigen-presenting cells. FASEB J (2004) 0.93

Platelet factor 4 (PF-4)-induced neutrophil adhesion is controlled by src-kinases, whereas PF-4-mediated exocytosis requires the additional activation of p38 MAP kinase and phosphatidylinositol 3-kinase. Blood (2003) 0.92

Platelet factor 4 (CXC chemokine ligand 4) differentially regulates respiratory burst, survival, and cytokine expression of human monocytes by using distinct signaling pathways. J Immunol (2007) 0.92

Genetic control of chemokines in severe human internal carotid artery stenosis. Cytokine (2007) 0.91

Cloning of a full-length cDNA encoding the neutrophil-activating peptide ENA-78 from human platelets. Gene (1994) 0.87

Mast cells and neutrophils proteolytically activate chemokine precursor CTAP-III and are subject to counterregulation by PF-4 through inhibition of chymase and cathepsin G. Blood (2005) 0.86

Role of the platelet in atherogenesis. Ann N Y Acad Sci (1976) 0.83

Laminar shear stress-induced GRO mRNA and protein expression in endothelial cells. Circulation (1998) 0.82

Intra-platelet platelet factor 4 (IP.PF4) and the heparin-mobilisable pool of PF4 in health and atherosclerosis. Thromb Haemost (1984) 0.80

Connective tissue-activating peptide III desensitizes chemokine receptors on neutrophils. Requirement for proteolytic formation of the neutrophil-activating peptide 2. J Immunol (1994) 0.79

Occurrence of platelet basic protein, a precursor of low affinity platelet factor 4 and beta-thromboglobulin, in human platelets and megakaryocytes. Exp Hematol (1988) 0.78

Articles by these authors

Development of monocytes, macrophages, and dendritic cells. Science (2010) 12.86

Phagocytosis of apoptotic neutrophils regulates granulopoiesis via IL-23 and IL-17. Immunity (2005) 6.71

Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol (2009) 5.28

Circulating activated platelets exacerbate atherosclerosis in mice deficient in apolipoprotein E. Nat Med (2002) 4.02

Vascular adhesion molecules in atherosclerosis. Arterioscler Thromb Vasc Biol (2007) 3.83

Local-pooled-error test for identifying differentially expressed genes with a small number of replicated microarrays. Bioinformatics (2003) 3.75

Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent. J Exp Med (2006) 3.65

Chemokines and chemokine receptors in leukocyte trafficking. Am J Physiol Regul Integr Comp Physiol (2002) 3.38

Complete reversal of acid-induced acute lung injury by blocking of platelet-neutrophil aggregation. J Clin Invest (2006) 3.38

Acute cardiovascular protective effects of corticosteroids are mediated by non-transcriptional activation of endothelial nitric oxide synthase. Nat Med (2002) 3.17

Critical role of endothelial CXCR2 in LPS-induced neutrophil migration into the lung. J Clin Invest (2006) 2.76

Deposition of platelet RANTES triggering monocyte recruitment requires P-selectin and is involved in neointima formation after arterial injury. Circulation (2002) 2.69

Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice. Circulation (2010) 2.69

Targeted disruption of cd73/ecto-5'-nucleotidase alters thromboregulation and augments vascular inflammatory response. Circ Res (2004) 2.68

Interleukin-17 signaling in inflammatory, Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice. Gastroenterology (2012) 2.58

P-selectin glycoprotein ligand-1-deficient mice have impaired leukocyte tethering to E-selectin under flow. J Clin Invest (2002) 2.45

Spleen tyrosine kinase Syk is necessary for E-selectin-induced alpha(L)beta(2) integrin-mediated rolling on intercellular adhesion molecule-1. Immunity (2007) 2.43

NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis. Circ Res (2011) 2.38

Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell (2012) 2.38

Sequential recruitment of neutrophils into lung and bronchoalveolar lavage fluid in LPS-induced acute lung injury. Am J Physiol Lung Cell Mol Physiol (2005) 2.28

Monocyte-endothelial cell interactions in the development of atherosclerosis. Trends Cardiovasc Med (2008) 2.22

Bacterial colonization factors control specificity and stability of the gut microbiota. Nature (2013) 2.20

Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. Blood (2011) 2.17

SDF-1alpha/CXCR4 axis is instrumental in neointimal hyperplasia and recruitment of smooth muscle progenitor cells. Circ Res (2005) 2.15

Disrupting functional interactions between platelet chemokines inhibits atherosclerosis in hyperlipidemic mice. Nat Med (2009) 2.15

Single injection of P-selectin or P-selectin glycoprotein ligand-1 monoclonal antibody blocks neointima formation after arterial injury in apolipoprotein E-deficient mice. Circulation (2003) 2.11

Platelet-neutrophil-interactions: linking hemostasis and inflammation. Blood Rev (2006) 2.08

Preferential migration of effector CD8+ T cells into the interstitium of the normal lung. J Clin Invest (2005) 2.07

M1 and M2 macrophages: the chicken and the egg of immunity. J Innate Immun (2014) 2.06

Protective effects of isoflurane pretreatment in endotoxin-induced lung injury. Anesthesiology (2006) 1.99

The primary defect in experimental ileitis originates from a nonhematopoietic source. J Exp Med (2006) 1.96

Control of leukocyte rolling velocity in TNF-alpha-induced inflammation by LFA-1 and Mac-1. Blood (2002) 1.92

Near-wall micro-PIV reveals a hydrodynamically relevant endothelial surface layer in venules in vivo. Biophys J (2003) 1.90

CXCR2- and E-selectin-induced neutrophil arrest during inflammation in vivo. J Exp Med (2004) 1.89

Leukocyte recruitment and vascular injury in diabetic nephropathy. J Am Soc Nephrol (2006) 1.89

Vav GEFs are required for beta2 integrin-dependent functions of neutrophils. J Cell Biol (2004) 1.87

Sphingosine kinase 2 is required for modulation of lymphocyte traffic by FTY720. J Biol Chem (2005) 1.84

Opening the flood-gates: how neutrophil-endothelial interactions regulate permeability. Trends Immunol (2009) 1.82

Binding and detachment dynamics of microbubbles targeted to P-selectin under controlled shear flow. J Control Release (2004) 1.81

Sphingosine-1 phosphate prevents monocyte/endothelial interactions in type 1 diabetic NOD mice through activation of the S1P1 receptor. Circ Res (2006) 1.81

Homeostatic regulation of blood neutrophil counts. J Immunol (2008) 1.81

Neutrophil-derived cathelicidin promotes adhesion of classical monocytes. Circ Res (2013) 1.80

PSGL-1 engagement by E-selectin signals through Src kinase Fgr and ITAM adapters DAP12 and FcR gamma to induce slow leukocyte rolling. J Exp Med (2008) 1.79

Macrophage differentiation to foam cells. Curr Pharm Des (2005) 1.77

Microviscometry reveals reduced blood viscosity and altered shear rate and shear stress profiles in microvessels after hemodilution. Proc Natl Acad Sci U S A (2004) 1.77

Endothelial cell PECAM-1 promotes atherosclerotic lesions in areas of disturbed flow in ApoE-deficient mice. Arterioscler Thromb Vasc Biol (2008) 1.76

P-selectin glycoprotein ligand-1 mediates L-selectin-dependent leukocyte rolling in venules. J Exp Med (2003) 1.73

Global metabolic inhibitors of sialyl- and fucosyltransferases remodel the glycome. Nat Chem Biol (2012) 1.70

Critical role of macrophage 12/15-lipoxygenase for atherosclerosis in apolipoprotein E-deficient mice. Circulation (2004) 1.70

Neutrophil adhesion and activation under flow. Microcirculation (2009) 1.67

Tracking leukocytes in vivo with shape and size constrained active contours. IEEE Trans Med Imaging (2002) 1.67

Cells on the run: shear-regulated integrin activation in leukocyte rolling and arrest on endothelial cells. Curr Opin Cell Biol (2008) 1.67

Distinct roles for talin-1 and kindlin-3 in LFA-1 extension and affinity regulation. Blood (2012) 1.64

Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol (2005) 1.63

Therapeutic anti-inflammatory effects of myeloid cell adenosine receptor A2a stimulation in lipopolysaccharide-induced lung injury. J Immunol (2007) 1.62

Glycosylation in immune cell trafficking. Immunol Rev (2009) 1.61

Identification of novel downstream targets of platelet glycoprotein VI activation by differential proteome analysis: implications for thrombus formation. Blood (2010) 1.61

Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis. J Clin Invest (2012) 1.57

Bench-to-bedside review: acute respiratory distress syndrome - how neutrophils migrate into the lung. Crit Care (2004) 1.57

Induction of dendritic cell-like phenotype in macrophages during foam cell formation. Physiol Genomics (2007) 1.51

Small molecule-mediated activation of the integrin CD11b/CD18 reduces inflammatory disease. Sci Signal (2011) 1.51

Sialyltransferase specificity in selectin ligand formation. Blood (2002) 1.50

Expanded B cell population blocks regulatory T cells and exacerbates ileitis in a murine model of Crohn disease. J Clin Invest (2004) 1.50

The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunity. Immunity (2013) 1.49

Sequential Immune Responses: The Weapons of Immunity. J Innate Immun (2015) 1.47

Circulating monocyte subsets and cardiovascular risk factors in coronary artery disease. Thromb Haemost (2010) 1.46

The platelet microparticle proteome. J Proteome Res (2005) 1.42

ICAM-1 and LFA-1 play critical roles in LPS-induced neutrophil recruitment into the alveolar space. Am J Physiol Lung Cell Mol Physiol (2006) 1.41

IL-17A inhibits the expansion of IL-17A-producing T cells in mice through "short-loop" inhibition via IL-17 receptor. J Immunol (2008) 1.41

CXC chemokine ligand 4 induces a unique transcriptome in monocyte-derived macrophages. J Immunol (2010) 1.41

Tyrosine kinase Btk regulates E-selectin-mediated integrin activation and neutrophil recruitment by controlling phospholipase C (PLC) gamma2 and PI3Kgamma pathways. Blood (2010) 1.40

Leukocyte influx in atherosclerosis. Curr Drug Targets (2007) 1.40

Initiation of protein O glycosylation by the polypeptide GalNAcT-1 in vascular biology and humoral immunity. Mol Cell Biol (2007) 1.38

Mechanisms and consequences of neutrophil interaction with the endothelium. Am J Pathol (2007) 1.38

Deformable gas-filled microbubbles targeted to P-selectin. J Control Release (2006) 1.37

Rolling on E- or P-selectin induces the extended but not high-affinity conformation of LFA-1 in neutrophils. Blood (2010) 1.37

Flow cytometry analysis of immune cells within murine aortas. J Vis Exp (2011) 1.37

scVEGF microbubble ultrasound contrast agents: a novel probe for ultrasound molecular imaging of tumor angiogenesis. Invest Radiol (2010) 1.35

IL-23 is required for neutrophil homeostasis in normal and neutrophilic mice. J Immunol (2007) 1.35

Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes. J Immunol (2007) 1.32

Macrophage inflammatory markers are associated with subclinical carotid artery disease in women with human immunodeficiency virus or hepatitis C virus infection. Arterioscler Thromb Vasc Biol (2014) 1.32

Induction of LFA-1-dependent neutrophil rolling on ICAM-1 by engagement of E-selectin. Microcirculation (2006) 1.30

Sialyltransferase ST3Gal-IV controls CXCR2-mediated firm leukocyte arrest during inflammation. J Exp Med (2008) 1.27

CXCR6 promotes atherosclerosis by supporting T-cell homing, interferon-gamma production, and macrophage accumulation in the aortic wall. Circulation (2007) 1.27

Mac-1, but not LFA-1, uses intercellular adhesion molecule-1 to mediate slow leukocyte rolling in TNF-alpha-induced inflammation. J Immunol (2003) 1.25

Leukocyte phosphoinositide-3 kinase {gamma} is required for chemokine-induced, sustained adhesion under flow in vivo. J Leukoc Biol (2006) 1.25

'Slings' enable neutrophil rolling at high shear. Nature (2012) 1.25

IL-17A controls IL-17F production and maintains blood neutrophil counts in mice. J Immunol (2009) 1.25

Autoperfused mouse flow chamber reveals synergistic neutrophil accumulation through P-selectin and E-selectin. J Leukoc Biol (2004) 1.22

Biomechanics of leukocyte rolling. Biorheology (2011) 1.20

Analysis of leukocyte rolling in vivo and in vitro. Methods Enzymol (2006) 1.20

Induction of vascular permeability: beta PIX and GIT1 scaffold the activation of extracellular signal-regulated kinase by PAK. Mol Biol Cell (2007) 1.20

GRO family chemokines are specialized for monocyte arrest from flow. Am J Physiol Heart Circ Physiol (2005) 1.20

Rap1a activation by CalDAG-GEFI and p38 MAPK is involved in E-selectin-dependent slow leukocyte rolling. Eur J Immunol (2011) 1.19

Crucial role of the CCL2/CCR2 axis in neointimal hyperplasia after arterial injury in hyperlipidemic mice involves early monocyte recruitment and CCL2 presentation on platelets. Circ Res (2004) 1.19

Disruption of platelet-derived chemokine heteromers prevents neutrophil extravasation in acute lung injury. Am J Respir Crit Care Med (2012) 1.18

Antibody blockade of CCL25/CCR9 ameliorates early but not late chronic murine ileitis. Gastroenterology (2006) 1.18

Quantitative dynamic footprinting microscopy reveals mechanisms of neutrophil rolling. Nat Methods (2010) 1.17

SAMP1/YitFc mouse strain: a spontaneous model of Crohn's disease-like ileitis. Inflamm Bowel Dis (2011) 1.17